From Patient Registry to Multi-Center Research Consortium: the Toxicology Investigators Consortium (ToxIC) Turns Fifteen
- PMID: 38935267
- PMCID: PMC11288211
- DOI: 10.1007/s13181-024-01020-1
From Patient Registry to Multi-Center Research Consortium: the Toxicology Investigators Consortium (ToxIC) Turns Fifteen
Abstract
The Toxicology Investigators Consortium (ToxIC) was launched as a prospective multi-center registry of cases who receive medical toxicology consultations. Now, with over 100,000 cases, the Core Registry continues to address many medical toxicology research questions and has served as the foundation for multiple sub-registries, including the North American Snakebite Registry and the Medications for Opioid Use Disorder sub-registry. ToxIC also has evolved a portfolio of non-registry-based projects utilizing medical toxicology physician site principal investigators who enroll patients through emergency departments, irrespective of whether they received a medical toxicology consultation. These studies include the FDA-ACMT COVID-19 ToxIC Pharmacovigilance Project, which identifies adverse drug reactions related to the treatment of COVID-19, the Fentalog Study a toxico-surveillance study of suspected opioid overdose cases, the Drug Overdose Toxico-Surveillance Reporting Program which enrolls either suspected stimulant or opioid overdose cases, and the just being launched Real-World Examination of Naloxone for Drug Overdose Reversal project. Given ToxIC's experience in multi-center studies and its well-developed infrastructure, it is well-positioned to provide a nimble response on the part of the medical toxicology community to addressing evolving toxicological threats, drug and chemical toxicosurveillance, and other important medical toxicology priorities.
Keywords: Epidemiology; Medical Toxicology; Overdose; Poisoning; Surveillance.
© 2024. American College of Medical Toxicology.
Conflict of interest statement
None.
Figures



References
-
- Wax PM, Brent J. The current status of the practice of inpatient medical toxicology at the bedside in the US. Clin Toxicol (Phila). 2009;47(7):740.
MeSH terms
Grants and funding
- U.S. Food and Drug Administration/U.S. Food and Drug Administration
- Centers for Disease Control and Prevention/CC/CDC HHS/United States
- BTG International/BTG International
- American Academy of Addiction Psychiatry/American Academy of Addiction Psychiatry
- Centers for Disease Control and Prevention/CC/CDC HHS/United States
LinkOut - more resources
Full Text Sources
Medical